重组人生长分化因子7，His-标签（GDF7）

重组人生长分化因子7，His-标签（GDF7）

Human GDF7 Protein, His tag | 货号：PRP1230

产品概述：本产品为大肠杆菌表达的重组人源GDF7蛋白片段，含His-TrxA双标签系统，经SDS-PAGE验证纯度>95%，内毒素含量<0.1 EU/μg，适用于细胞培养等研究场景。

核心参数

• 物种来源：人源（Homo sapiens）
• 氨基酸序列：Thr322-Arg450（UniProt ID：Q7Z4P5）
• 分子量：14.07 kDa（125个氨基酸构成）
• 表达系统：大肠杆菌表达体系
• 生物活性：活性验证中（Testing in progress）

质量控制

• 纯度验证：还原性SDS-PAGE检测
• 内毒素：LAL法检测＜0.1 EU/μg
• 形态：冻干粉（PBS缓冲液，pH7.4）

产品规格

规格	价格（RMB）	货期
5 μg	588	现货
20 μg	1,498	现货
100 μg	5,969	现货
1 mg	询价	询价

使用指南

• 复溶建议：使用配套复溶缓冲液，浓度≥100 μg/mL
• 保存条件：冻干粉-20℃保存，复溶后4℃保存≤7天，长期保存需-20℃并添加0.1%载体蛋白
• 运输方式：蓝冰运输

警告：本品仅供科研使用，不可用于临床诊断或人体实验。使用前请确认不违反相关专利许可。

注意：以上信息可能随着产品优化升级等因素产生变动，具体信息请咨询亚科因公司。

Recombinant Human Growth Differentiation Factor 7, His-tag (GDF7)

Human GDF7 Protein, His tag | Cat. No.: PRP1230

Product Overview: This product is a recombinant human GDF7 protein fragment expressed in E. coli, containing a His-TrxA dual-tag system. The purity is verified by SDS-PAGE to be >95%, with endotoxin content <0.1 EU/μg, suitable for cell culture and other research applications.

Key Parameters

• Species Source: Human (Homo sapiens)
• Amino Acid Sequence: Thr322-Arg450 (UniProt ID: Q7Z4P5)
• Molecular Weight: 14.07 kDa (125 amino acids)
• Expression System: E. coli expression system
• Biological Activity: Testing in progress

Quality Control

• Purity Verification: Reducing SDS-PAGE
• Endotoxin: LAL assay <0.1 EU/μg
• Form: Lyophilized powder (PBS buffer, pH 7.4)

Product Specifications

Specification	Price (RMB)	Lead Time
5 μg	588	In stock
20 μg	1,498	In stock
100 μg	5,969	In stock
1 mg	Inquiry	Inquiry

Usage Guidelines

• Reconstitution Recommendation: Use the provided reconstitution buffer, concentration ≥100 μg/mL
• Storage Conditions: Lyophilized powder stored at -20°C, reconstituted solution stored at 4°C for ≤7 days, long-term storage at -20°C with 0.1% carrier protein
• Shipping Method: Blue ice shipping

Warning: This product is for research use only and not for clinical diagnosis or human experiments. Please ensure compliance with relevant patent licenses before use.

Note: The above information may change due to product optimization and upgrades. For specific information, please consult Abbkine.